4
Changes in Ownership
Aurinia Pharmaceuticals Inc. Filed Acc 0001628280-21-004740
Chief Medical Officer sold 40,000 shares at $13.49 ($539,600)
- Chief Medical Officer acquired 40,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Solomons Neil Chief Medical Officer | 2021-03-12 | Option exercise | +40,000 | $3.02 | $120,800 | 227,299 | D: show line 1 in the form |
| Solomons Neil Chief Medical Officer | 2021-03-12 | Sale | −40,000 | $13.49 | $539,600 | 187,299 | D: show line 2 in the form |
| Open-market sales · 40,000 sh · avg $13.49 · $539,600 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Solomons Neil Chief Medical Officer | 2021-03-12 | Option exercise · Stock Option (right to buy) | −40,000 | 0 | D: show line 3 in the form |
Loading xslF345X03/wf-form4_161584054793459.xml…